Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population

Gut

Volumn 56, Issue 2, 2007, Pages 210-214

  Guittet, L ^a   Bouvier, V ^a,b   Mariotte, N ^c   Vallee, J P ^b   Arsene D ^a   Boutreux, S ^a   Tichet, J ^c   Launoy, G ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b Association Mathilde   (France)

^c Institut Regional pour la Sante   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GUAIAC;

ADULT; AGED; ARTICLE; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; LABORATORY APPARATUS, EQUIPMENT AND SUPPLIES; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; PRIORITY JOURNAL;

ADENOMA; AGED; COLON; COLONOSCOPY; COLORECTAL NEOPLASMS; CONFIDENCE INTERVALS; FALSE POSITIVE REACTIONS; FEMALE; GUAIAC; HEMATOLOGIC TESTS; HUMANS; IMMUNOCHEMISTRY; INDICATORS AND REAGENTS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 33846973387     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.101428     Document Type: Article

References (27)

1. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71.
2. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
3. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
4. Faivre J, Dancourt V, Lejeune C, et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 2004;126:1674-80.
5. Allison JE. Colon Cancer Screening Guidelines 2005: the fecal occult blood test option has become a better FIT. Gastroenterology 2005;129:745-8.
6. Greenwald B. From guaiac to immune fecal occult blood tests: the emergence of technology in colorectal cancer screening. Gastroenterol Nurs 2005;28:90-6.
7. Bond JH. The place of fecal occult blood test in colorectal cancer screening in 2006: the U.S. perspective. Am J Gastroenterol 2006;101:219-21.
8. Vilkin A, Rozen P, Levi Z, et al. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test. Am J Gastroenterol 2005;100:2519-25.
9. Morikawa T, Kato J, Yamaji Y, et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005;129:422-8.
10. Wong WM, Lam SK, Cheung KL, et al. Evaluation of an automated immunochemical fecal occult blood test for colorectal neoplasia detection in a Chinese population. Cancer 2003;97:2420-4.
11. Schatzkin A, Connor RJ, Taylor PR, et al. Comparing new and old screening tests when a reference procedure cannot be performed on all screenees. Example of automated cytometry for early detection of cervical cancer. Am J Epidemiol 1987;125:672-8.
12. Cheng H, Macaluso M. Comparison of the accuracy of two tests with a confirmatory procedure limited to positive results. Epidemiology 1997;8:104-6.
13. Chock C, Irwig L, Berry G, et al. Comparing dichotomous screening tests when individuals negative on both tests are not verified. J Clin Epidemiol 1997;50:1211-17.
14. Rozen P, Knaani J, Samuel Z. Comparative screening with a sensitive guaiac and specific immunochemical occult blood test in an endoscopic study. Cancer 2000;89:46-52.
15. Allison JE, Tekawa IS, Ransom LJ, et al. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 1996;334:155-9.
16. Zappa M, Castiglione G, Paci E, et al. Measuring interval cancers in population-based screening using different assays of fecal occult blood testing: the District of Florence experience. Int J Cancer 2001;92:151-4.
17. Launoy GD, Bertrand HJ, Berchi C, et al. Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population. Int J Cancer 2005;115:493-6.
18. Cheng H, Macaluso M, Hardin JM. Validity and coverage of estimates of relative accuracy. Ann Epidemiol 2000;10:251-60.
19. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale - Update based on new evidence. Gastroenterology 2003;124:544-60.
20. Achkar E, Moayyedi P. Colorectal cancer screening with fecal occult blood testing (FOBT): an international perspective. Am J Gastroenterol 2006;101:212.
21. Young GP, St John DJ, Winawer SJ, et al. Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol 2002;97:2499-507.
22. Nakama H, Zhang B, Kamijo N. Sensitivity of immunochemical fecal occult blood test for colorectal flat adenomas. Hepatogastroenterology 2004;51:1333-6.
23. Hughes K, Leggett B, Del Mar C, et al. Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community. Aust N Z J Public Health 2005;29:358-64.
24. Berchi C, Bouvier V, Reaud JM, et al. Cost-effectiveness analysis of two strategies for mass screening for colorectal cancer in France. Health Econ 2004;13:227-38.
25. Castiglione G, Grazzini G, Miccinesi G, et al. Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood. J Med Screen 2002;9:99-103.
26. Cole SR, Young GP, Esterman A, et al. A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen 2003;10:117-22.
27. Federici A, Giorgi Rossi P, Borgia P, et al. The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial. J Med Screen 2005;12:83-8.